Stay updated on Arimoclomol in Gaucher Disease Type 1 or 3 Clinical Trial

Sign up to get notified when there's something new on the Arimoclomol in Gaucher Disease Type 1 or 3 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Arimoclomol in Gaucher Disease Type 1 or 3 Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The footer now identifies the ClinicalTrials.gov site as revision v3.8.0 instead of v3.7.2.
    Difference
    0.1%
    Check dated 2026-11-02T12:54:29.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    A site-wide banner announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence.”
    Difference
    0.8%
    Check dated 2026-10-26T12:49:18.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-19T13:35:18.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The footer’s site revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-12T14:34:31.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    New revision entry v3.7.0 was added to the study record history, reflecting an update to the record’s documentation. The previous revision v3.6.6 appears removed from the visible history, indicating a revision history update rather than changes to trial data.
    Difference
    0.1%
    Check dated 2026-09-21T21:53:25.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    There are no new changes to the study record history for this page. The data set contains no additions or deletions to summarize.
    Difference
    0.1%
    Check dated 2026-09-14T19:22:34.000Z thumbnail image

Stay in the know with updates to Arimoclomol in Gaucher Disease Type 1 or 3 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Arimoclomol in Gaucher Disease Type 1 or 3 Clinical Trial page.